ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 — Stella

Recruiting

Back to Prostate Cancer trials

Trial locations(1 site)

Italy

Radiation Oncology, Fondazione IRCCS San Gerardo dei Tintori, Monza, MB

Key details

Sponsor

University of Milano Bicocca

Enrollment target

~58 participants

Started

January 2026

Primary completion

July 2029

Age range

18 Years – 90 Years

Sex

Male only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov